SBI Securities’s Biofrontera BFRI Stock Holding History

SBI Securities’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$349	Buy	323 +18	+6%	+$23	﹤0.01%	3231
2026 Q2	$288	Hold	305	–	–	﹤0.01%	3209
2026 Q1	$247	Buy	305 +5	+2%	+$4	﹤0.01%	3141
2025 Q4	$171	Sell	300 -1	-0.3%	-$1	﹤0.01%	3257
2025 Q3	$296	Sell	301 -1	-0.3%	-$1	﹤0.01%	3197
2025 Q2	$215	Sell	302 -7	-2%	-$5	﹤0.01%	3284
2025 Q1	$247	Buy	309 +3	+1%	+$3	﹤0.01%	3143
2024 Q4	$334	Buy	+306	New	+$289	﹤0.01%	3041

Other funds holding BFRI

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

SBI Securities's BFRI Position: Q3 2026 in Review

SBI Securities increased its Biofrontera (BFRI) stake by 5.9% in Q3 2026, buying an estimated $23 and bringing the position to 323 shares worth $349. The position accounts for ﹤0.01% of the portfolio, ranked #3231.

SBI Securities first reported a position in BFRI in Q4 2024 and has held it in 8 quarters since. 2 funds tracked by Wall St. Rank hold BFRI as of Q3 2026.

SBI Securities held 323 shares of Biofrontera worth $349 as of Q3 2026.
SBI Securities bought 18 Biofrontera shares in Q3 2026, an estimated $23.
Biofrontera made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3231 holding.
SBI Securities first reported a position in Biofrontera in Q4 2024 and has held it in 8 quarters since.
2 funds tracked by Wall St. Rank held Biofrontera as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.